25 Feb 2022

This scientific output, approved on 30 November 2021, supersedes the previous output published on 24 April 2015 (EFSA Guidance, 2014). The European Commission will decide the implementation time for the mandatory use of this guidance in the regulatory context.

24 Feb 2022

EFSA asked the Panel to deliver a Scientific Opinion on testing and interpretation of comparative in vitro metabolism studies for both new active substances and existing ones ...

22 Feb 2022

This new publication from the European Commission Joint Research Centre (JRC) makes actionable recommendations ...

17 Dec 2021

EFSA draft opinion proposes lowering the tolerable daily intake for Bisphenol A

18 Oct 2021

Abstracts can be submitted for consideration for a Platform or Poster Session presentation ...

22 Jul 2021

The testing strategy consists of three so-called alternative methods. They can be used to predict whether a substance causes allergic reactions in the skin. Unlike in the past, animal testing will no longer be necessary for this ...

25 Jun 2021

The June 2021 OECD Chemical Safety and Biosafety Progress Report describes activities and publications on Adverse Outcome Pathways (AOP) in risk assessment ...

7 Jun 2021

The recently published study on maternal occupational exposure to endocrine-disrupting chemicals during pregnancy and semen parameters in adulthood (Istvan et al., Human Reprod. 2021) which was co-funded by SCAHT has received widespread attention. Here is a statement by the SCAHT to help putting the study findings into context ...

1 Jun 2021

We wish him all the best for the future and are looking forward to his continuing support as consultant in regulatory projects and through teaching in our master courses.

25 May 2021

The scientific committee would like to encourage poster contributions from young toxicologists ...